Quick Answer
Cosmos Health Inc. reported R&D Expense of $533.3 thousand for fiscal year 2024.
Cosmos Health Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $533.3K | +223.5% |
| 2023 | $164.9K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $18.3K | — | -75.4% |
| June 30, 2025 | $74.6K | — | +377.6% |
| March 31, 2025 | $15.6K | — | — |
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | — | — |
- Cosmos Health Inc. showed an increase of +223.5% in R&D Expense compared to the prior fiscal year.
- Over the 2023–2024 period, Cosmos Health Inc.’s r&d expense has grown by 223.5% (from $164.9 thousand to $533.3 thousand).
- The most recent figure is from Cosmos Health Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: